Medistem Commences Pre-Clinical Research With Lawson Health Research Institute in London, Ontario in the Treatment of ... (Market Wire via Yahoo! Finance)
Medistem Laboratories, Inc. (Frankfurt: S2U) announced today that it is collaborating with Dr. Hao Wang, researcher at Lawson Health Research Institute and Assistant Professor, Department of Surgery at The University of Western Ontario in London, Ontario, to conduct pre-clinical research on Medistem's proprietary platform Tolerostem(TM). Subject to positive research results Medistem plans to ...

DOR BioPharma Announces FDA Clearance to Conduct Phase 2 Clinical Trial of orBec(R) for the Prevention of GVHD (RedNova)
DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company") announced that it has received clearance from the U.S. Food and Drug Administration ("FDA") to conduct a Phase 2 clinical trial of orBec(R) for the prevention of Graft-versus-Host disease ("GVHD").